Company Data
Spruce Biosciences Inc.
Ticker
SPRB
Current Price
$70.3 3.53%
Market Cap
$96.5M
Price Target
Refer to Report
Volume
32.0K
52wk Range
$7.26 - $835.875
Overview
Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders. The company is developing its wholly-owned product candidate, tildacerfont, as the potential first non-steroidal therapy to offer improved disease control and reduce steroid burden for patients suffering from classic congenital adrenal hyperplasia (CAH).